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Abstract
Background: Peroxisomes are organelles whose roles in fatty acid metabolism and reactive oxygen species
elimination have contributed much attention in understanding their origin and biogenesis. Many studies have
shown that de novo peroxisome biogenesis is an important regulatory process, while yeast studies suggest that
total peroxisome numbers are in part regulated by proteins such as Pex11, which can facilitate the division of
existing peroxisomes. Although de novo biogenesis and divisions are likely important mechanisms, the regulation
of peroxisome numbers during embryonic development is poorly understood. Peroxisome number and function
are particularly crucial in oviparous animals such as frogs where large embryonic yolk and fatty acid stores must be
quickly metabolized, and resulting reactive oxygen species eliminated. Here we elucidate the role of Pex11b in
regulating peroxisomal gene expression and number in Xenopus laevis embryogenesis.
Results: Microinjecting haemagglutinin (HA) tagged Pex11b in early embryos resulted in increased RNA levels for
peroxisome related genes PMP70 and catalase at developmental stages 10 and 20, versus uninjected embryos.
Catalase and PMP70 proteins were found in punctate structures at stage 20 in control embryos, whereas the
injection of ectopic HA-Pex11b induced their earlier localization in punctate structures at stage 10. Furthermore,
the peroxisomal marker GFP-SKL, which was found localized as peroxisome-like structures at stage 20, was similarly
found at stage 10 when co-microinjected with HA-Pex11b.
Conclusions: Overexpressed Pex11b altered peroxisomal gene levels and induced the early formation of
peroxisomes-like structures during development, both of which demonstrate that Pex11b may be a key regulator
of peroxisome number in early Xenopus embryos.
Background
Peroxisomes are single-membrane bound organelles
found ubiquitously in eukaryotic cells. They house more
than 50 matrix enzymes that participate in a diverse
array of metabolic processes including the b-oxidation
of very long chain fatty acids (VLCFA) and a-oxidation
of long branched-chain fatty acids [1]. Peroxisomes also
contain oxidases that produce the corrosive byproduct
hydrogen peroxide (H2O2)[ 2 ] .H 2O2 and other danger-
ous reactive oxygen species (ROS) are then converted to
innocuous products such as water and molecular oxygen
by catalase and other enzymes within the peroxisome
and in other cellular compartments [3]. Because of their
complex roles in both cellular metabolism and ROS
elimination, peroxisome function is strongly related to
cellular development and eventual cellular senescence
when their functionality begins to fail.
While cellular aging and senescence are well charac-
terized by peroxisomal dysfunction [4], little is known
about the origin of these organelles, particularly during
embryonic development. Important players in the regu-
lation of overall peroxisome numbers are the peroxi-
some proliferator-activated receptors (PPARs), which
were first identified in the early 90s in mice [5]. Three
types of PPARs have been identified (alpha, gamma, and
delta) that function as transcription factors and play cri-
tical physiological roles as lipid sensors and regulators
of lipid metabolism, as well in the regulation peroxisome
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tantly, peroxisome biogenesis, involves the production of
proteins termed peroxins; nuclear encoded by Pex
genes, synthesized on free polyribosomes in the cytosol
and post-translationally transported into the peroxiso-
mal matrix and membrane [7]. Peroxins can facilitate
peroxisomal membrane function, biogenesis and divi-
sion, and the transport of specific cytosolic proteins into
the peroxisomal matrix via one of two peroxisomal tar-
geting signals (PTS) [8]. The PTS2 signal sequence is a
complex amino terminal signal composed of N/K-L-X5-
Q-H/L, while the PTS1 consists of the C-terminal
amino acid sequence SKL and a conserved variant form,
KANL [9]. Studies have shown proteins with the SKL
signal have a higher affinity for peroxisomes than pro-
teins with the relatively weaker KANL signal [10]. In
addition to providing functionality within peroxisomes,
these cytoplasm-to-peroxisome protein import pathways
have been proposed as a necessary mechanism to
increase peroxisome numbers from existing peroxisomes
[11]. While peroxisome number may be augmented
though signal transduction [12,13], the total number of
peroxisomes in a cell is regulated by; (i) peroxisome de
novo biogenesis, (ii) peroxisome proliferation by division
and (iii) peroxisome degradation by pexophagy, an
autophagy-related process [14].
Multiple studies on Pex11 proteins have contributed
to understanding their role in peroxisome division,
although the specific molecular mechanisms that regu-
late their function are poorly understood [13]. Expres-
sion levels of Pex11 peroxins are directly correlated with
peroxisome numbers [15]. For example, a Pex11p
knock-down in yeast significantly reduced the amount
of cellular peroxisomes, whereas, Pex11p overexpression
increase their numbers [16]. A similar ability to promote
peroxisome proliferation was also reported in humans
[13], rodents and protozoan models [17]. All of these
studies support a direct role for the Pex11-family in per-
oxisome division in vitro, though little is known about
their role during embryogenesis.
It is unknown whether peroxisomes exist in fertilized
eggs, or in early stage vertebrate embryos. While early
frog development requires glycogen and lipid reserves to
be oxidized, and protein and yolk reserves to be meta-
bolized, surprisingly little is known about the regulation
of yolk, vitellogenin and lipid metabolism in oviparous
animals such as frogs. Early histological staining studies
revealed that yolk and lipid utilization follow gastrula-
tion, but preceded cell differentiation. Selman and Paw-
sey revealed that frog yolk and lipid utilization took
place ventral to the archenteron just prior to stage 20,
and within the developing myotomes by stage 23 [18].
Other histochemical studies have also shown that yolk
and lipid metabolism occurs within the somites as they
begin to differentiate between stages 17-24 [19]. Yolk is
then metabolized in most differentiating tissues in the
embryo after stage 30 [19]. This tissue specific utiliza-
tion of yolk has been more recently confirmed using a
variety of approaches including the examination of pH
changes, and the involvement of proteases such as
cathepsin D, and inhibitors such as EP45/pNiXa/Seryp
[20-23]. This tissue specific regulation of yolk metabo-
lism during embryogenesis suggests complex underlying
developmental controls of these processes.
While peroxisomes are needed for metabolism and
ROS regulation, their origins and biogenesis within the
embryo are poorly understood. Here we examine the
level of expression of peroxisomal genes Pex1, Pex3,
Pex5, Pex11b, catalase and PMP70, as well as PPARa, δ,
and g in a X. laevis cell line, and during embryonic
development. We test the hypothesis that Pex11b has
the ability to induce peroxisomal gene expression in
vitro, and induce early increase in peroxisome number
in vivo. Our results demonstrate that overexpression of
Pex11b can increase the number of peroxisomes in
Xenopus A6 cells in vitro, and induce an early-onset to
peroxisome-like structures during Xenopus embryogen-
esis in vivo. We propose that Pex11b plays a direct role
in peroxisome divisions, and additionally, regulating the
timing of peroxisome biogenesis during X. laevis
embryonic development.
Results
Pex11b altered the RNA levels of peroxisome related
genes in X. laevis A6 cells
W ef i r s ti n v e s t i g a t e di fP e x 1 1 b could alter the RNA
levels of the peroxisome related genes Pex1, Pex3, Pex5,
Pex11b, catalase, PMP70, PPARa,- δ,a n d- g in X. laevis
A6 kidney epithelial cells, something that has not been
demonstrated in Xenopus before. A6 cells were trans-
fected with plasmids designed to express Xenopus HA-
Pex11b, or control full-length GFP. Semi-quantitative
RT-PCR analyses revealed a significant increase in
Pex11b, PMP70, catalase, Pex5 and PPARa, but a signif-
icant decrease in PPARg mRNA levels, following HA-
Pex11b overexpression in A6 cells (Figure 1). No signifi-
cant changes were found in levels of Pex3, Pex1, nor in
PPAR δ mRNA (Figure 1).
Pex11b increased hallmark peroxisomal protein levels in
X. laevis A6 cells
Since overexpression of HA-Pex11b increased the
mRNA levels of catalase and PMP70, we next wanted to
determine if there were actual increases in the protein
levels of these hallmark peroxisomal proteins. A6 cells
were transfected as previously described and protein
samples were isolated for Western blots. Using a specific
HA antibody, Western blot analysis confirmed bands of
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samples (Figuer 2A), confirming the integrity of the
HA-tagged construct. Western blot analyses with cata-
lase and PMP70 specific antibodies also revealed bands
of expected sizes for both PMP70 (70 kDa) and catalase
(55 kDa) (Figure 2). A significant increase in catalase
and in PMP70 were found following HA-Pex11b overex-
pression versus control untransfected samples (Figure
2A, left three GFP lanes versus right three HA-Pex11b
lanes, and quantified in Figure 2B). The use of anti-b-
a c t i nd e m o n s t r a t e dt h er e l a t i v ep r o t e i nl e v e l si ne a c h
lane.
Overexpression of Pex11b increased peroxisome numbers
in X. laevis A6 cells
Although recent studies in several eukaryotic cell lines
have revealed that Pex11-proteins can independently
increase peroxisome-like structures [18], we tested the
hypothesis that Pex11b could induce an early onset to
peroxisome biogenesis during Xenopus embryogenesis.
However, we first tested whether overexpression of
Pex11b could increase peroxisome-like structures and
peroxisome number in X. laevis A6 cells. Two days
following transfection of HA-Pex11b, cells were fixed
for immunocytochemistry and probed with PMP70
and catalase antibodies. This allowed us to examine
the distribution of PMP70 and catalase protein, and
also to quantify their relative protein levels using a
fluorescent secondary antibody. Our results indicated
that overexpression of HA-Pex11b significantly
increased the amounts of both catalase levels (Figure
3A versus 3B) and PMP70 levels (Figure 3D versus
3E) versus control, as determined by quantifying the
relative levels of indirect fluorescent; catalase indirect
fluorescence levels increased >3 fold (Figure 3C),
while PMP70 indirect fluorescence levels increased
>2.5 fold (Figure 3F).
Figure 1 Overexpressing HA-Pex11b altered peroxisome
related gene expression in Xenopus A6 cells. RT-PCR analysis of
peroxisomal genes was performed before and after transfection of
A6 cells with HA-Pex11b. Two days following transfection 250 ng of
reverse-transcribed A6 cell RNAs from control and treatment
samples (n = 3) were subject to PCR amplification using specific
primers for the peroxisome related genes; Pex11b, PMP70, catalase,
Pex5, Pex3, Pex1, PPARa,- δ, and -g. The respective mRNA levels
represent measures of mid-log phase RT-PCR product band
intensities, relative to levels of EF1a. Genes whose levels were
altered significantly, as assessed by an independent samples t-test,
are denoted with an asterisk. Pex11b, PMP70, catalase, Pex5 and
PPARa displayed elevated levels of expression following treatment,
while PPARg displayed reduced expression. P < 0.05, n = 3. Values
presented are the means ± SE.
Figure 2 Overexpression of HA-Pex11b in A6 cells increased catalase and PMP70 protein levels. Western blotting revealed elevated
proteins levels of catalase and PMP70 following the transfections of HA-Pex11b, but not GFP, in three samples of A6 cells (A). An HA antibody
confirmed the translation and presence of HA-Pex11b in transfected cells (right 3 lanes) versus GFP transfected control cells (left 3 lanes).
Catalase and PMP70 antibodies also displayed altered band intensities of each respective protein in HA-Pex11b transfected cells (right 3 lanes)
versus GFP transfected cells (left 3 lanes). Protein loading in each lane was confirmed via a b-actin antibody. The Western blot signals were
digitized and data were quantified and analyzed to statistically compare protein levels (B). There was a significant increase in the levels of
catalase and PMP70 following overexpression of Pex11b, while there was no difference in the levels of b-actin. Statistical relevance of
discrepancies between groups (asterisks) was assessed by an independent samples t-test. P < 0.05, n = 3. Values presented are the means ± SE.
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cent signals may not specifically be related to peroxisome
function, we next tested if overexpression of HA-Pex11b
could also increase the number of peroxisomes using the
peroxisomal marker GFP-SKL as a detection assay. This
PTS1 tagged GFP will localize to punctate-like structures
in the cytosol when imported into peroxisomes. A6 cells
were co-transfected with HA-Pex11b and GFP-SKL, or
GFP-SKL alone. Two days following transfection, peroxi-
some-like structures were assessed by direct immuno-
fluorescence. Our results showed a significant increase in
the number GFP-containing bodies (>2-fold, Figure 3I) in
cells that expressed HA-Pex11b versus cells transfected
with GFP-SKL alone (compare Figure 3G and 3H).
Pex11b increased peroxisome related gene expression
during X. laevis embryogenesis
We next examined the effects of increased Pex11b in
vivo, by investigating changes in expression of specific
peroxisomal genes, following the microinjection HA-
Pex11b RNA into early Xenopus embryos. To establish
a foundation, the temporal expression of five peroxiso-
mal genes was first analyzed during the developmental
stages of gastrulation (stage 10), neural tube closure
(stages 20) and organogenesis (stage 30). In general,
with the exception of Pex5, all peroxisomal genes exam-
ined in control embryos increased in expression as
development progressed, with their lowest expression
levels at stage 10, and highest at stage 30 (Figure 4,
Figure 3 Overexpression of HA-Pex11b in A6 cells increased peroxisome numbers. A, D, G are untransfected cells, while B, E, H have been
transfected with HA-Pex11b. G and H are additionally transfected with GFP-SKL. Using identical imaging and photography parameters, indirect
immunofluorescence using a catalase antibody revealed lower levels of immunofluorescence in untransfected cells (A) versus transfected (B)
cells. Similarly, indirect immunofluorescence using a PMP70 antibody revealed lower levels of signal in untransfected cells (D) versus transfected
(E). Direct fluorescence for GFP revealed a diffuse signal from GFP in HA-Pex11b untransfected cells, (G) versus the presence of punctate
structures in HA-Pex11b transfected cells (H). All images were captured using identical fluorescent settings. The relative fluorescence intensity in
10 regions of twenty randomly imaged cells was quantified using Northern Eclipse software. Graphs on the right represent the average
fluorescence intensity of untransfected versus HA-Pex11b transfected cells. Values presented are the means ± SE. Significance at P < 0.05 was
determined using Student’s t-test, n = 25.
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Pex5 expression in control embryos does not alter sig-
nificantly between stages 10 and 30. The increase in
PMP70 RNA level between stages 10 and 20 differs
from that a previously described decreasing trend
between stages 12 and 20 [23]. This difference could be
due to the examination of different stages (stage 10 vs
12), though in both cases the more important trend of
increasing levels towards stage 30 and beyond is the
same. Following microinjection of HA-Pex11b RNA
there were significantly increased RNA levels of catalase
and PMP70 at stages 10, 20 and 30 (Figure 4, single
asterisk) versus control RNA levels of expression for
each gene. Microinjecting HA-Pex11b also resulted in
significant increases of Pex3 at stages 10 and 30, as well
as Pex5 at stages 20 and 30. There were no significant
changes in Pex3 at stage 20, nor Pex5 at stage 10.
Changes in Pex11b levels following microinjection of
HA-Pex11b reflect the presence of the HA-Pex11b
construct.
Further, as ectopic Pex11b significantly decreased
PPARg RNA levels in A6 cells, we investigated whether
ectopic Pex11b would similarly alter PPAR levels within
embryos. The injection of Pex11b into embryos signifi-
cantly increased levels of PPARa, significantly decreased
levels of PPARg, but did not change levels of PPARδ
RNA (Figure 5), a pattern similar to that seen in the A6
cells.
Catalase and PMP70 antibodies reveal early punctate
organelle structures during X. laevis embryogenesis
following Pex11b injections
To determine if Pex11b could induce an early onset to
peroxisome-like structures during Xenopus develop-
ment, we used immunohistochemistry to visualize
changes in the embryonic distribution of PMP70 and
catalase, in response to microinjecting HA-Pex11b RNA.
Fertilized embryos were microinjected with HA-Pex11b
RNA, fixed at stages 10 and 20, and sectioned for
immunohistochemistry. PMP70 and catalase signals
Figure 4 Embryonic overexpression of HA-Pex11b elevated Pex3, catalase and PMP70 levels. The respective mRNA levels represent
measures of mid-log phase RT-PCR product band intensities, relative to levels of EF1a. RT-PCR analysis during normal embryogenesis revealed
that the levels of all genes examined, with the exception of Pex5, increased as development progressed. First, repeated measures ANOVAs were
carried out entering all RNA levels at all 3 stages. When significant, paired samples t-tests were carried out between stage levels in control
embryos. This would reveal significant changes in RNA levels of the genes examined during normal development. Significant changes in RNA
levels of a gene between stages is represented by the double asterisk ** (P < 0.05). Expression increases with development and there are
differences in the levels of Pex3 and PMP70 between all stages, 10vs20, 20vs30 and 10 versus 30. For catalase there are differences between
stages 10vs20 and 10vs30 but NOT between 20 versus 30. There are no significant differences in RNA levels between the tested developmental
stages for Pex11b or Pex5. As the means were correlated, MANOVAs were carried out on the mean RNA levels of the treatment and control
groups at each stage for each gene. All MANOVAs displayed significant effects of condition (Wilks lambda, P < 0.05) and so univariate ANOVAs
were carried out. Treatments that resulted in significantly higher levels of gene expression following treatment are represented by a single
asterisk. Pex11b, catalase and PMP70 all displayed significant increases in RNA levels all stage 10, stage 20 and stage 30 following treatment.
Pex3 displayed elevated expression at only stage 10 and 30, while Pex5 displayed differences only at stages 20 and 30. (Ps < 0.05). n = 3. Values
presented are the means ± SE.
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(Figure 6A and 7A) using specific antibodies. Punctate
structures were visualized within the somites at stage 20
in control sections, using PMP70 (Figure 6B), and cata-
lase (Figure 7B) specific antibodies. Following microin-
jection of HA-Pex11b,w ew e r ea b l et od e t e c t e d
punctate PMP70 (Figure 6C) and catalase (Figure 7C)
signals at stage 10 in pre-somitic mesoderm, and
increased levels of immunofluorescence for both pro-
teins in stage 20 somites compared to control uninjected
embryos (compare Figure 6B vs 6D, and 7B vs 7D).
Overexpression of Pex11b triggered an early-onset to
peroxisome accumulation during Xenopus embryogenesis
In order to determine when peroxisomes are first pre-
sent during embryonic development, focusing on the
dorsal mesoderm, we microinjected GFP-SKL into early-
fertilized embryos. Histological sections taken of devel-
opmental stage 10 embryos revealed that peroxisomes
were not visible, as GFP-SKL revealed a diffuse staining
pattern that lacked punctate structures (Figure 8A),
similar to that seen in control GFP injections embryos
(data not shown). However, GFP-containing punctate
bodies, indicative of peroxisomes, are readily visible in
control embryos at stage 20 in the somites (Figure 8B).
Next, we wanted to determine if overexpression of
Pex11b could induce an accumulation of peroxisomes,
similar to how overexpression in A6 cells increased per-
oxisome numbers. Histological sections showed that
ectopic expression of HA-Pex11b in embryos resulted in
the presence of punctate GFP-containing bodies at stage
10 (Figure 8C), versus the diffuse pattern of GFP-SKL
seen at this stage in the dorsal structures of uninjected
embryos (Figure 8A). Further, there was also a relative
increase in the number of punctate structures at stage
20 following HA-Pex11b and GFP-SKL (Figure 8D),
compared to the microinjection of GFP-SKL alone (Fig-
ure 8B).
Discussion
Pex11 proteins were first identified in yeast as peroxiso-
mal membrane proteins that could increase peroxisome
number when overexpressed and significantly reduce
peroxisome number when interrupted [24]. Early studies
suggested that Pex11 proteins acted primarily on med-
ium-chain fatty acid oxidation, affecting peroxisome
divisions indirectly [16]. Schrader and colleagues were
the first to show in human fibroblasts that overexpres-
sion of human Pex11b was sufficient to induce peroxi-
some proliferation [25]. Recently, it has been shown that
Pex11b participates in peroxisome divisions through
membrane elongation and shape changes of existing
Figure 5 Overexpression of HA-Pex11b did altered PPARa and
g, but not δ, gene expression during early X. laevis
embryogenesis. The respective mRNA levels represent measures of
mid-log phase RT-PCR product band intensities, relative to levels of
EF1a. Using a similar approach and analysis as used in Figure 4, RT-
PCR analysis of RNA isolated from control stage 10 embryos and
HA-Pex11b injected embryos revealed significant changes in the
expression of PPARa, and PPARg, but not PPARδ. PPARa levels were
elevated by treatment, while PPARg levels were reduced. P < 0.05,n
= 3. Values presented are the means ± SE.
Figure 6 Microinjecting HA-Pex11b RNA increased PMP70
immunofluorescence levels during X. laevis embryogenesis.
Both control (A and B) and HA-Pex11b injected (C and D) embryos
at developmental stages 10 (A and C) and 20 (B and D), were fixed
then sectioned for immunohistochemical analysis in somites for
PMP70. At stage 10 PMP70 protein is undetected in somitic
mesoderm under control conditions (A), whereas following
microinjection of HA-Pex11b PMP70 protein is detectable in
punctate structures (C). At stage 20, PMP70 protein was detected in
both control and following microinjecting HA-Pex11b (B and D). An
HA antibody was also used to confirm the ectopic presence of HA-
Pex11b. DAPI (blue), PMP70 (green), HA-Pex11b (red), colocalization
of HA-Pex11b and catalase (yellow). Images were taken at 60×
magnification.
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matrix proteins, form into small blebs and separate into
new peroxisomes with the aid of dynamin-like protein
[26]. While yeast studies have shown that peroxisomes
only arise through division [27], and mammalian cell
studies have suggested that they arise from both de novo
and division mechanisms [28], little is known about per-
oxisome biogenesis during embryonic development. The
question of peroxisome inheritance remains largely
u n r e s o l v e d ,p a r t i c u l a r l ya sw eh a v es h o w nt h a tp e r o x i -
somes are absent in early frog embryos, and arise only
later due to embryonic and or metabolic cues [29].
We tested whether overexpression of Pex11b could
induce an early-onset to peroxisome biogenesis or accu-
mulation during early Xenopus embryogenesis. This is
particularly intriguing, as stage 10 embryos have no
detectable peroxisomes. Thus, as Pex11b participates in
peroxisome division, and no detectable peroxisomes are
present in early embryos, Xenopus represents a novel
model where the role of Pex11b in peroxisome number
can be examined. The utility of microinjection and rela-
tive ease of expression and localization assays enables
specific questions related to Pex11b to be addressed.
First, we sought to show that Pex11b is sufficient to reg-
ulate peroxisome related protein and RNA levels, and
increase the number of peroxisomes in X. laevis A6
cells. Our RT-PCR analysis indicated significant
increases in RNA levels for both catalase and PMP70,
amongst other genes, following overexpression of
Pex11b. Using Western blot analysis we confirmed that
HA-Pex11b increased catalase and PMP70 proteins
levels, and immunohistochemistry confirmed that HA-
Pex11b increased the number of both catalase and
PMP70 positive punctate structures in A6 cells. Addi-
tionally, as GFP-SKL can be transported into peroxi-
somes, co-transfection of HA-Pex11b and GFP-SKL
revealed an increase in the number of peroxisome-like
structures. These results strongly support the idea that
Pex11b can independently promote increases to the
number of peroxisomes in Xenopus A6 cells.
The primary focus of our study was to elucidate the
role of Pex11b in vivo. Very little is known about what
cellular mechanisms regulate the de novo biogenesis of
Figure 8 Microinjecting HA-Pex11b RNA increased the number
of peroxisome-like GFP-SKL structures during X. laevis
embryogenesis. Both control (A and B) and HA-Pex11b injected (C
and D) embryos at developmental stages 10 (A and C) and 20 (B
and D), were fixed then sectioned for immunohistochemical analysis
in somites for GFP-SKL. At stage 10, GFP fluorescence is present as a
faint diffuse stain under control conditions (A), whereas following
microinjection of HA-Pex11b punctate GFP structures could be seen
at this early stage (C). At stage 20, punctate GFP structures were
detected in both control and following microinjecting HA-Pex11b,
where numbers were increased in the injected samples. An HA
antibody was also used to confirm the ectopic presence of HA-
Pex11b. DAPI (blue), GFP (green), HA-Pex11b (red), colocalization of
HA-Pex11b and GFP-SKL (yellow). Images were taken at 60×
magnification.
Figure 7 Microinjecting HA-Pex11b RNA increased catalase
immunofluorescence levels during X. laevis embryogenesis.
Both control (A and B) and HA-Pex11b injected (C and D) embryos
at developmental stages 10 (A and C) and 20 (B and D), were fixed
then sectioned for immunohistochemical analysis in somites for
catalase. At stage 10 catalase protein is undetected in somitic
mesoderm under control conditions (A), whereas following
microinjection of HA-Pex11b catalase protein is detectable in
punctate structures (C). At stage 20, PMP70 protein was detected in
both control and following microinjecting HA-Pex11b (B and D). An
HA antibody was also used to confirm the ectopic presence of HA-
Pex11b. DAPI (blue), PMP70 (green), HA-Pex11b (red), colocalization
of HA-Pex11b and PMP70 (yellow). Images were taken at 60×
magnification.
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ferent GFP-KANL reporter, we had previously reported
their detection at stage 30 in the ectoderm [29]. Histo-
chemical studies in frog have suggested that yolk protein
and lipid metabolism occurs at different stages in differ-
ent tissues [22,30]. Interestingly, early yolk metabolism
is seen in the newly formed muscles - the somites, but
not in the large yolk-filled endodermal cells that are
present on the ventral side of the embryo [22,30]. Here,
using HA-Pex11b and other specific assays, we demon-
strate that peroxisomes are detectable in somites at
stage 20, but not at stage 10.
In agreement with the presence of peroxisome by
stage 20, the RNA levels of most peroxisomal genes
examined changed temporally during early development.
Pex11b Pex3, Catalase, and PMP70 showed increasing
trends in expression as development proceeded, peaking
stage 30, with cytosolic-bound peroxisomal receptor
Pex5 not varying during these stages. This suggested
that transcripts are present and increasing towards the
eventual onset of peroxisome biogenesis and/or their
subsequent proliferation. These changes in Pex3 and
Pex11b RNA levels relate well with previous studies that
have demonstrated their roles in division [31]. If Pex11b
did play a key regulatory role, we next determined how
microinjecting HA-Pex11b mRNA would affect the rela-
tive levels of key peroxisomal genes. Changes of Pex11b
RNA levels simply reflect and confirm the presence on
the transfected construct. The Pex11b resulted in the
significant increases in RNA levels for catalase and
PMP70 at all stages tested (10, 20 and 30). There were
also increases in the levels of Pex3 and Pex5 at two of
the three stages examined, however, these changes were
not as dramatic. From this data, we conclude that
Pex11b can play a role in the early induction of these
peroxisomal genes. Interestingly, as was examined with
Pex11b in A6 cells, PPARa RNA levels increased,
PPARg decreased, and PPARδ was unchanged by ectopic
Pex11b in embryos. Given that PPARa has roles in the
b-oxidation of fatty acids, PPARg role in lipid catabolism
and adipocyte differentiation, and that while expressed
ubiquitously, PPARδ functions remain unclear, the sig-
nificance of our findings are not known. Furthermore,
the relationship between PPARs, other metabolic regula-
tors, yolk utilization and peroxisome numbers certainly
bears further investigation.
We focused on the distribution of catalase and PMP70
protein within the somites and found that catalase and
PMP70 proteins are first localized as punctate structures
suggestive of peroxisomes at stage 20, with no detect-
able signal at stage 10. To corroborate this immunologi-
cal finding we microinjected GFP-SKL RNA, whose
product could be transported into peroxisomes. Our
stage 10 histology sections revealed diffuse signals from
GFP, indicating that peroxisomes are not yet present, as
the SKL-tagged GFP was not localized. However, we
were able to show that GFP-SKL localized to punctate-
like structures in the somites at stage 20, indicating that
peroxisomes are present at this stage.
With these results in mind, we next tested whether
microinjecting HA-Pex11b RNA could induce an early
accumulation to the number of peroxisomes. While per-
oxisomes are present at stage 20, perhaps all needed
precursors are present earlier in the embryo and waiting
a developmental or metabolic cue to form functional
peroxisomes. Following the microinjection of HA-
Pex11b, we were able to visualize peroxisome-like struc-
tures using GFP-SKL at stage 10. This suggested that
needed peroxisomal precursors, including matrix pro-
teins and other division proteins, such as dynamin-like
proteins are present. Interestingly, together with the
data that showed that HA-Pex11b injections increased
the transcription of peroxisomal genes, this suggests
that Pex11b is a key regulator of peroxisome onset and
proliferation during Xenopus development. For the first
time, we are able to show that Pex11b can indepen-
dently induce an early onset to peroxisome accumula-
tion in vivo.
Conclusions
From our data we conclude that Xenopus Pex11b plays
a role in regulating peroxisome number both in A6 cells
in vitro and in vivo in embryos. Ectopic expression in
vivo demonstrated for the first time Pex11b’s ability to
induce peroxisome related gene expression, and addi-
tionally to promote the early formation of peroxisome-
like structures in embryos.
Methods
Animal Care
Adult X. laevis were reared in accordance with Canadian
Council on Animal Care regulations. Fertilizations were
performed according to Wu and Gerhart [32], and
embryos were staged according to Nieuwkoop and
Faber [33]. Embryos to be sectioned were fixed in 4%
formaldehyde at desired stages and paraffin-embedded.
Cloning, RNA Synthesis, and Microinjection
We cloned Xenopus full length Pex11b [GenBank:
MGC69071] from total adult liver cDNA using specific
primers using and SuperScript™ Reverse Transcriptase
(Invitrogen) with Platinum
® Taq DNA Polymerase High
Fidelity (Invitrogen) using conditions supplied by the
manufacturer. A 5’ HA tag was added to Pex11b using
specific primers; HA-Pex11b 5’AGA TCT TCA AGC
GTA ATC TGG TAC GTC GTA TGG GTA GGG
CTT CAG CTT CAG CCA 3’ and 5’ CGA ACC CAC
GAG TCC ATA CTA GT 3’.W ea l s oe n g i n e e r e dG F P
Fox et al. BMC Developmental Biology 2011, 11:24
http://www.biomedcentral.com/1471-213X/11/24
Page 8 of 11tagged with the PTS1 SKL, using forward 5’ AGA TCT
ATG GTG AGC AAG GGC GAG 3’ and 5’ ACT AGT
CTA TAA TTT GGA CTT GTA CAG CTC GTC CA
3’. PCR products were cloned into the pCR
®II-TOPO
vector as per manufacturer’s instructions (Invitrogen).
Recombinant sequences were confirmed at the Robarts
Research Institute DNA Sequencing Facility at the Uni-
versity of Western Ontario. Desired clones were addi-
tionally cloned into pcDNA™TOPO 3.3
® TA Cloning
Kit (Invitrogen) for cell culture experiments, and T7TS
plasmid and sequenced in vitro RNA production.
Capped polyadenylated RNA was synthesized using
mMachine mMessage
® T7 (Ambion) and visualized on
a 1.0% agarose formaldehyde gel to ensure quality and
transcription validity. Embryos at the one-cell stage in
4% ficoll in 1X Marks Modified Ringer (MMR) solution
were microinjected with approximately 1 ng of desired
RNA. Following 4 hours, embryos were transferred to
0.1X MMR for rearing.
Cell lines, Transfections and Immunocytochemistry
A6 cells derived from X. laevis epithelial cells (generous
gift from Dr. John Heikkila, University of Waterloo,
ON) were grown in Leibowitz-15 media (with 10% FBS
and 1% penicillin and streptomycin) at room tempera-
ture. All transfections were completed using Lipofecta-
mine Plus LTX Transfection Reagents (Invitrogen)
according to manufactures protocol. For immunofluor-
escence, cells were fixed in 3.7% formaldehyde in Dul-
becco’s modified PBS (DPBS) (Invitrogen), pH 7.4, for
10 min, and permeabilized in 1% Triton X-100 in DPBS
for 10 min. Cells were incubated with either PMP70
(Abcam, ab4965) or catalase (Cedarlane), and/or hae-
magglutinin (Invitrogen) polyclonal antibodies for 3
hours, washed three times in PBST for 5 minutes each,
incubated with fluorescently labeled secondary antibo-
dies for 1 hour, washed again for 5 minutes in DPBS,
and mounted on slides using ProGold mounting media
(Invitrogen). Samples were visualized with a Zeiss Axio-
Stop 2 Mot. Images were captured with a Retiga 1600
camera (Qimaging) and fluorescence quantifications
were completed using Northern Eclipse image capture
and analysis software (Empix).
RNA Isolations and Reverse Transcriptase PCR (RT-PCR)
RNA was isolated from cell lysates of all samples two
days following transfections. Total RNA was isolated
with an RNeasy kit (QIAGEN) from embryos at devel-
opmental stages 10, 20, 30, and from A6 cells, was
evaluated on a 1.0% agarose formaldehyde gel. Synthesis
of cDNA was completed with SuperScript II Reverse
Transcriptase (Invitrogen) following manufactures pro-
tocol. To analyze RNA expression levels during develop-
ment, RT-PCR primers were designed against known
Xenopus peroxisomal and PPAR as follows; Pex1
[NM_001091972.1] forward 5’ CTT ATG GAG AAA
TGT TTG GTT AAG A 3’ and reverse 5’ TTC ACG
TGA TTG CAT TCT CAG ACT 3’,P e x 3[ E M B L :
AAH73069.1] forward 5’ ATC CAG CAT TCA GCA
CCT TCT AGG 3’ and reverse 5’ ATC TGA TTC CTC
CCC ATT TAG GC 3’, Pex5 [NP_001011381] forward
5’ CAG AAC AGG CAG ATC CCA TGT CCT 3’ and
reverse 5’ ATC CTC TTT ACA AAC TGT AAG AAC
3’,P e x 1 1 b [MGC69071] forward 5’ TGC GAC AAC
ATT CTG TGG GTC GGG AA 3’ and reverse 5’ CGA
CAC CAT TAT CCT CAC TCA GT 3’,P M P 7 0
[EF07060] forward 5’ TTG GAT GAT TCA GAA TGG
TAC TT 3’ and reverse 5’ AAC CTT TCA ACA TCT
TGT GTA AGC A 3’, Catalase [BC054964] forward 5’
GAG AAC ATT GGG AAG AGA ACT CCA AT 3’ and
reverse 5’ CTT CAA ATG AGT CTG TGG GTT CCT
TTT C 3’, PPAR alpha [NM_001095362] forward 5’
CCA TCC TGA TTG GGA AAG CCA GCA CTC 3’
and reverse 5’ CTA CGA GGC CAT GTT TGC CAT
GCT GGC GT 3’, PPAR delta [NM_001087841] forward
5’ TTA CAG GAA CAG AGA TTG GAG TTC A 3’
and reverse 5’ CTC CAA GTT CAA TGC CCT GGA
ACT TAA TG 3’, PPAR gamma [NM_001087843] for-
ward 5’ AGG AGA AAT TAT TGG CTG AAA TCT
CCA G 3’ and reverse 5’ G A CC T GA A CG A CC A A
GTG ACG CTG CTG AA 3’ and EF1-alpha forward 5’
CAG ATT GGT GCT GGA TAT GC 3’ and reverse 5’
ACT GCC TTG ATG ACT CCT AG 3’, genes with the
following accession numbers: Pex3 [EMBL:
AAH73069.1], Pex5 [NP_001011381], Pex11b [GenBank:
MGC69071], PMP70 [EF07060], catalase [BC054964],
Pex1 [NM_001091972.1], PPARa [NM_001095362],
PPARδ [NM_001087841], and PPARg [NM_001087843].
Mid-log phase RT-PCR products were visualized on a
1% agarose gel and unsaturated band intensities were
quantified against control elongation factor-1a [NCBI:
NM_001087442] with Quantity One software (Version
4.4.0 Bio-Rad). As the Xenopus genome has not been
fully annotated, only primers for Pex3, PMP70 and EF1-
a could be confirmed to span intron sequences. These
particular primers sets therefore confirmed that there
was no genomic DNA contamination in the cDNA sam-
ples used. All quantified PCR reactions were completed
in triplicate. The amplicons of peroxisomal genes listed
above were cloned with the TOPO-TA Cloning
® (Invi-
trogen) system as described by the manufacturer’sp r o -
tocol and sequenced to ensure gene identities.
Western Blot Analysis
PMP70 (Abcam, ab4965), catalase (Cedarlane), hemag-
glutinin and b-actin (Invitrogen) polyclonal antibodies
were used to detect protein from both X. laevis A6 cell
lysates before and after treatments. Bradford protein
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Page 9 of 11quantifications were used to ensure that equivalent
amounts of protein (10 mg) were loaded for each sam-
ple [34]. Primary antibodies were used in a 1 in 1000
dilution and secondary 1 in 10,000 dilution, and blots
were developed using an enhanced chemiluminescence
kit (Amersham). Band intensities were quantified using
Quantity One software (Version 4.4.0 Bio-Rad).
Immunohistochemistry
Paraffin-embedded embryo sections were washed in
Xylene and re-hydrated by washing in 100, 90, 80 and
70% ethanol each for 10 minutes twice, followed by 10
min in 0.1% Tween-20 in PBS twice. Histology sections
to be immunostained were incubated with a 24-hour
primary followed by a two-hour secondary (FITC or
Texas Red conjugated) antibody incubation in a 1 in
100 antibody dilution. Embryos were counterstained
with DAPI (Invitrogen) according to the manufacturer’s
protocol. Images were captured and fluorescence quanti-
fied with a Zeiss LSM Dou (Live 5 Vario II and 510
Meta) Confocal system using Northern Eclipse image
capture and analysis software (Empix).
Statistical Analyses
Tests of significance are described within figure legends
as required.
Acknowledgements
This work was funded by a Natural Sciences and Engineering Research
Council of Canada (NSERC) operating grant to SD. We would like to thank
Drs. Robert C. Cumming and Gregory M. Kelly for their comments and
intellectual contribution to this study, and Richard Harris and Karen Nygard
for their assistance with microscopy.
Authors’ contributions
MF designed and performed all experiments. MF and SD wrote, critically
read and approved the final manuscript. MN helped with immunoblot
interpretation. LW assisted with immunohistochemical experiments. All
authors read and approved the final manuscript.
Received: 24 January 2011 Accepted: 28 April 2011
Published: 28 April 2011
References
1. Wanders RJ, Vreken P, Ferdinandusse S, Jansen GA, Waterham HR, van
Roermund CW, Van Grunsven EG: Peroxisomal fatty acid alpha- and beta-
oxidation in humans: enzymology, peroxisomal metabolite transporters
and peroxisomal diseases. Biochem Soc Trans 2001, 29:250-67.
2. Singh I: Biochemistry of peroxisomes in health and disease. Mol Cell
Biochem 1997, 167:1-29.
3. Anand P, Kwak Y, Simha R, Donaldson RP: Hydrogen peroxide induced
oxidation of peroxisomal malate synthase and catalase. Arch Biochem
Biophys 2009, 491:25-31.
4. Legakis JE, Koepke JI, Jedeszko C, Barlaskar F, Terlecky LJ, Edwards HJ,
Walton PA, Terlecky SR: Peroxisome senescence in human fibroblasts. Mol
Biol Cell 2002, 13:4243-55.
5. Issemann I, Green S: Activation of a member of the steroid hormone
receptor superfamily by peroxisome proliferators. Nature 1990,
347:645-50.
6. Desvergne B, Michalik L, Wahli W: Transcriptional regulation of
metabolism. Physiol Rev 2006, 86:465-514.
7. Duhita N, HA Le, Satoshi S, Kazuo H, Daisuke M, Takao S: The origin of
peroxisomes: The possibility of an actinobacterial symbiosis. Gene 2010,
450:18-24.
8. Dodt G, Braverman N, Wong C, Moser A, Moser HW, Watkins P, Valle D,
Gould SJ: Mutations in the PTS1 receptor gene, PXR1, define
complementation group 2 of the peroxisome biogenesis disorders. Nat
Genet 1995, 9:115-25.
9. Wolf J, Schliebs W, Erdmann R: Peroxisomes as dynamic organelles:
peroxisomal matrix protein import. FEBS J 2010, 277:3268-78.
10. Koepke JI, Nakrieko KA, Wood CS, Boucher KK, Terlecky LJ, Walton PA,
Terlecky SR: Restoration of peroxisomal catalase import in a model of
human cellular aging. Traffic 2007, 8:1590-600.
11. Ma C, Subramani S: Peroxisome matrix and membrane protein
biogenesis. IUBMB Life 2009, 61:713-22.
12. Titorenko VI, Rachubinski RA: The peroxisome: orchestrating important
developmental decisions from inside the cell. J Cell Biol 2004, 164:641-5.
13. Li X, Gould SJ: PEX11 promotes peroxisome division independently of
peroxisome metabolism. J Cell Biol 2002, 156:643-51.
14. Platta HW, Erdmann R: Peroxisomal dynamics. Trends Cell Biol 2007,
17:474-84.
15. Kaur N, Hu J: Dynamics of peroxisome abundance: a tale of division and
proliferation. Curr Opin Plant Biol 2009, 12:781-8.
16. van Roermund CW, Tabak HF, van Den Berg M, Wanders RJ, Hettema EH:
Pex11p plays a primary role in medium-chain fatty acid oxidation, a
process that affects peroxisome number and size in Saccharomyces
cerevisiae. J Cell Biol 2000, 150:489-98.
17. Schrader M, Fahimi HD: Growth and division of peroxisomes. Int Rev Cytol
2006, 255:237-90.
18. Selman GG, Pawsey GJ: The utilization of yolk platelets by tissues of
Xenopus embryos studied by a safranin staining method. J Embryol Exp
Morphol 1965, 14:191-212.
19. Kielbowna L: Utilization of yolk platelets and lipid bodies during the
myogenesis of Xenopus laevis (Daudin). Cell Tissue Res 1975, 159:279-86.
20. Fagotto F: Regulation of yolk degradation, or how to make sleepy
lysosomes. J Cell Sci 1995, 108:3645-7.
21. Yoshizaki N, Yonezawa S: Cysteine proteinase plays a key role for the
initiation of yolk digestion during development of Xenopus laevis. Dev
Growth Differ 1998, 40:659-67.
22. Jorgensen P, Steen JA, Steen H, Kirschner MW: The mechanism and
pattern of yolk consumption provide insight into embryonic nutrition in
Xenopus. Development 2009, 136:1539-48.
23. Marteil G, D’Inca R, Pascal A, Guitton N, Midtun T, Goksøyr A, Richard-
Parpaillon L, Kubiak JZ: EP45 accumulates in growing Xenopus laevis
oocytes and has oocyte-maturation-enhancing activity involved in
oocyte quality. J Cell Sci 2010, 123:1805-13.
24. Karnati S, Baumgart-Vogt E: Peroxisomes in airway epithelia and future
prospects of these organelles for pulmonary cell biology. Histochem Cell
Biol 2009, 131:447-54.
25. Schrader M, Reuber BE, Morrell JC, Jimenez-Sanchez G, Obie C, Stroh TA,
Valle D, Schroer TA, Gould SJ: Expression of PEX11beta mediates
peroxisome proliferation in the absence of extracellular stimuli. J Biol
Chem 1998, 273:29607-14.
26. Delille HK, Agricola B, Guimaraes SC, Borta H, Luers GH, Fransen M,
Schrader M: Pex11pbeta-mediated growth and division of mammalian
peroxisomes follows a maturation pathway. J Cell Sci 2010, 123:2750-62.
27. Motley AM, Ward GP, Hettema EH: Dnm1p-dependent peroxisome fission
requires Caf4p, Mdv1p and Fis1p. J Cell Sci 2008, 121:1633-40.
28. Kim PK, Mullen RT, Schumann U, Lippincott-Schwartz J: The origin and
maintenance of mammalian peroxisomes involves a de novo PEX16-
dependent pathway from the ER. J Cell Biol 2006, 173:521-32.
29. Cooper CA, Walsh LA, Damjanovski S: Peroxisome biogenesis occurs in
late dorsal-anterior structures in the development of Xenopus laevis.
Dev Dyn 2007, 236:3554-61.
30. Mes-Hartree M, Armstrong JB: Lipid metabolism during embryonic and
early postembryonic development of Xenopus laevis. Can J Biochem
1980, 58:559-64.
31. Pinto MP, Grou CP, Fransen M, Sa-Miranda C, Azevedo JE: The cytosolic
domain of PEX3, a protein involved in the biogenesis of peroxisomes,
binds membrane lipids. Biochim Biophys Acta 2009, 1793:1669-75.
32. Wu M, Gerhart J: Raising Xenopus in the laboratory. Methods Cell Biol
1991, 36:3-18.
Fox et al. BMC Developmental Biology 2011, 11:24
http://www.biomedcentral.com/1471-213X/11/24
Page 10 of 1133. Nieuwkoop PD: The organization center of the amphibian embryo: its
origin, spatial organization, and morphogenetic action. Adv Morphog
1973, 10:1-39.
34. Bradford MM: A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye
binding. Anal Biochem 1976, 72:248-54.
doi:10.1186/1471-213X-11-24
Cite this article as: Fox et al.: PEX11b induces peroxisomal gene
expression and alters peroxisome number during early Xenopus laevis
development. BMC Developmental Biology 2011 11:24.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Fox et al. BMC Developmental Biology 2011, 11:24
http://www.biomedcentral.com/1471-213X/11/24
Page 11 of 11